Androgen deprivation therapy-related fracture risk in prostate cancer: an insurance claims database study in Japan.

ADT is associated with a 1.6-fold increase in the risk of osteoporotic fracture in men with prostate cancer. Densitometry in this population is infrequent and monitoring urgently needs to be improved in order to implement effective fracture prevention.